Mackenzie Financial
EXAS

Mackenzie Financial’s Exact Sciences EXAS Stock Holding History

Mackenzie Financial’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-812,115
Closed -$82.6M – 1528
2025
Q4 		$82.6M Sell
812,115
-1,931,704
-70% -$155M 0.1% 181
2025
Q3 		$150M Sell
2,743,819
-111,982
-4% -$5.6M 0.18% 117
2025
Q2 		$152M Sell
2,855,801
-425,838
-13% -$21.6M 0.2% 114
2025
Q1 		$142M Buy
3,281,639
+362,314
+12% +$18.3M 0.2% 120
2024
Q4 		$164M Buy
2,919,325
+1,513,873
+108% +$94.2M 0.22% 111
2024
Q3 		$95.7M Buy
1,405,452
+1,393,917
+12,084% +$78.7M 0.13% 146
2024
Q2 		$487K Buy
11,535
+2,325
+25% +$128K ﹤0.01% 1027
2024
Q1 		$636K Sell
9,210
-3,038
-25% -$192K ﹤0.01% 974
2023
Q4 		$906K Sell
12,248
-822
-6% -$53.9K ﹤0.01% 887
2023
Q3 		$857K Buy
13,070
+3,200
+32% +$272K ﹤0.01% 881
2023
Q2 		$921K Buy
+9,870
New +$770K ﹤0.01% 875
2022
Q3 		– Sell
-6,724
Closed -$265K – 1460
2022
Q2 		$265K Sell
6,724
-7,682
-53% -$411K ﹤0.01% 1144
2022
Q1 		$1.01M Buy
14,406
+8
+0.1% +$585 ﹤0.01% 892
2021
Q4 		$1.12M Buy
14,398
+605
+4% +$53.4K ﹤0.01% 885
2021
Q3 		$1.32M Buy
13,793
+2,054
+17% +$217K ﹤0.01% 850
2021
Q2 		$1.46M Buy
11,739
+602
+5% +$71.8K ﹤0.01% 786
2021
Q1 		$1.47M Buy
11,137
+3,544
+47% +$485K ﹤0.01% 744
2020
Q4 		$1.01M Buy
7,593
+3,324
+78% +$402K ﹤0.01% 712
2020
Q3 		$435K Sell
4,269
-1,595
-27% -$138K ﹤0.01% 809
2020
Q2 		$510K Buy
5,864
+2,048
+54% +$164K ﹤0.01% 789
2020
Q1 		$221K Buy
3,816
+689
+22% +$55.9K ﹤0.01% 968
2019
Q4 		$289K Sell
3,127
-3,090
-50% -$272K ﹤0.01% 960
2019
Q3 		$562K Sell
6,217
-3,044
-33% -$347K ﹤0.01% 812
2019
Q2 		$1.09M Sell
9,261
-1,758
-16% -$177K ﹤0.01% 738
2019
Q1 		$954K Buy
11,019
+5,875
+114% +$500K ﹤0.01% 935
2018
Q4 		$325K Buy
5,144
+23
+0.4% +$1.58K ﹤0.01% 1009
2018
Q3 		$404K Buy
5,121
+978
+24% +$63.8K ﹤0.01% 932
2018
Q2 		$248K Sell
4,143
-6,042
-59% -$325K ﹤0.01% 934
2018
Q1 		$411K Buy
+10,185
New +$497K ﹤0.01% 766
2017
Q2 		– Sell
-771,606
Closed -$18.2M – 633
2017
Q1 		$18.2M Buy
771,606
+474,800
+160% +$9.41M 0.11% 191
2016
Q4 		$3.96M Buy
296,806
+220,400
+288% +$3.56M 0.02% 306
2016
Q3 		$1.42M Sell
76,406
-683,779
-90% -$12M 0.01% 374
2016
Q2 		$9.31M Sell
760,185
-33,500
-4% -$252K 0.05% 257
2016
Q1 		$5.35M Sell
793,685
-367,694
-32% -$2.35M 0.05% 254
2015
Q4 		$10.7M Buy
1,161,379
+13,600
+1% +$126K 0.07% 236
2015
Q3 		$20.6M Buy
1,147,779
+119,600
+12% +$2.75M 0.13% 167
2015
Q2 		$30.6M Buy
1,028,179
+211,700
+26% +$5.32M 0.17% 147
2015
Q1 		$18M Buy
816,479
+62,600
+8% +$1.59M 0.09% 197
2014
Q4 		$20.7M Buy
753,879
+59,779
+9% +$1.45M 0.11% 171
2014
Q3 		$13.5M Sell
694,100
-14,600
-2% -$268K 0.07% 226
2014
Q2 		$12.1M Buy
708,700
+2,200
+0.3% +$30.3K 0.06% 247
2014
Q1 		$10M Sell
706,500
-84,100
-11% -$1.14M 0.05% 254
2013
Q4 		$9.29M Sell
790,600
-1,600
-0.2% -$18.4K 0.05% 245
2013
Q3 		$9.35M Buy
792,200
+115,200
+17% +$1.48M 0.05% 252
2013
Q2 		$9.42M Buy
+677,000
New +$7.35M 0.04% 261

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Mackenzie Financial's EXAS Position: Q1 2026 in Review

Mackenzie Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 812,115 shares — an estimated $82.6M sold.

Mackenzie Financial first reported a position in EXAS in Q2 2013 and held it in 45 quarters. The position peaked at $164M in Q4 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Mackenzie Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Mackenzie Financial sold 812,115 Exact Sciences shares in Q1 2026, an estimated $82.6M.
  • Mackenzie Financial first reported a position in Exact Sciences in Q2 2013 and held it in 45 quarters.
  • Mackenzie Financial's Exact Sciences position peaked at $164M in Q4 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Mackenzie Financial's 13F filing for Q1 2026, filed 13 May 2026.